-
Calcium supplementation in women; type 2 diabetes treatments and pancreatitis risk; treating chronic idiopathic urticaria; rivaroxaban and VTE; and FDA actions.
-
Early and aggressive treatment of seizures, educational and social habilitation, as well as treatment of psychiatric comorbidities is advisable in intellectually normal children with focal epilepsy (partial complex seizures with or without secondary generalization).
-
Direct current transcranial stimulation of the human brain holds promise for helping to improve a variety of neurological functions, including learning and memory.
-
-
Myocardial perfusion imaging (MPI) refers to the utilization of radiotracers to image regional myocardial perfusion from coronary artery blood flow to the heart muscle. Used effectively, MPI can provide the clinician with a noninvasive technique that yields both important diagnostic and powerful prognostic information regarding the functional significance of anatomic coronary artery disease.
-
In this issue: Aspirin use and AMD risk; using NSAIDs and antihypertensive agents; and FDA actions.
-
Herpes simplex virus encephalitis (HSE) is the most common cause of sporadic fatal viral encephalitis. Although the mortality and morbidity of HSE has been significantly reduced due to early antiviral therapy, even after treatment, about 35% of patients have severe neurological sequelae or even death.
-
Intravenous (IV) or intra-arterial treatment with tissue plasminogen activator (tPA) and mechanical clot extraction can limit the damage that some ischemic strokes cause, but they also can cause complications, including hemorrhage into established infarcts.
-
Juvenile myoclonic epilepsy (jme), sometimes called Janz syndrome, is the most common idiopathic generalized epilepsy and is characterized by multiplicity of seizure types, including myoclonic jerks on awakening, generalized tonic-clonic seizures, and absence seizures.
-
Dr. Henchcliffe reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmith-Kline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.